Sara D. Reis

Sara D. Reis

Auto-generated profile, based on publicly available information

Sara D. Reis

REQUIMTE/LAQV, Department of Drug Sciences, Pharmacology Lab, Faculty of Pharmacy, University of Porto, Porto, Portugal

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Pharmacological Research
Verified
Journal Article
Closed access
BPBrígida Pinho
Brígida Pinho
SRSara D. Reis
Sara D. Reis
PGPedro Guedes-Dias
Pedro Guedes-Dias
ALAna Leitão-Rocha
Ana Leitão-Rocha
Clara QuintasClara Quintas
Clara Quintas
Jorge M. A. OliveiraJorge M. A. Oliveira
Jorge M. A. Oliveira

1 January 2019 in Ageing Research Reviews
Verified
Journal Article
Open access
TSTânia R. Soares
Tânia R. Soares
SRSara D. Reis
Sara D. Reis
BPBrígida Pinho
Brígida Pinho
MDMichael R. Duchen
Michael R. Duchen
Jorge M. A. OliveiraJorge M. A. Oliveira
Jorge M. A. Oliveira
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion mutation in the huntingtin protein. Expansions above 40 polyglutamine repeats are invariably fatal, following a symptomatic period characterised by choreiform movements, behavioural abnormalities, and cognitive decline. While mutant huntingtin (mHtt) is widely expressed from early life, most patients with HD present in mid-adulthood, highlighting the role of ageing in disease pathogenesis. mHtt undergoes proteolytic cleavage, misfolding, accumulation, and aggregation into inclusion bodies. The emerging model of HD pathogenesis proposes that the chronic production of misfolded mHtt overwhelms the chaperone machinery, diverting other misfolded clients to the proteasome and the autophagy pathways, ultimately leading to a global collapse of the proteostasis network. Multiple converging hypotheses also implicate ageing and its impact in the dysfunction of organelles as additional contributing factors to the collapse of proteostasis in HD. In particular, mitochondrial function is required to sustain the activity of ATP-dependent chaperones and proteolytic machinery. Recent studies elucidating mitochondria-endoplasmic reticulum interactions and uncovering a dedicated proteostasis machinery in mitochondria, suggest that mitochondria play a more active role in the maintenance of cellular proteostasis than previously thought. The enhancement of cytosolic proteostasis pathways shows promise for HD treatment, protecting cells from the detrimental effects of mHtt accumulation. In this review, we consider how mHtt and its post translational modifications interfere with protein quality control pathways, and how the pharmacological and genetic modulation of components of the proteostasis network impact disease phenotypes in cellular and in vivo HD models.

12 August 2013 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
JCJoão Costa-Rodrigues
João Costa-Rodrigues
SRSara Reis
Sara Reis
STSónia Teixeira
Sónia Teixeira
SLSandra Lopes
Sandra Lopes
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Proton pump inhibitors (PPIs), a class of molecules that are used to decrease gastric acid production, might have adverse effects on bone metabolism. The aim of this study was to characterize the concentration‐dependent and time‐dependent effects of three PPIs (omeprazole, esomeprazole, and lansoprazole) on human osteoclast precursor cells isolated from peripheral blood, and on human mesenchymal stem cells (osteoblast precursors). Cell cultures were characterized for total protein content, apoptosis, and several osteoclastic/osteoblastic features, and also for the involvement of some intracellular signaling pathways. PPIs caused a dose‐dependent decrease in cellular density, which correlated with an increase in the apoptosis rate, effects that became statistically significant at concentrations ≥ 10−5 m. They also inhibited phenotype‐related gene expression and functional parameters. For both cell types, cellular function, i.e. osteoclastic resorption and the formation of mineralized deposits by osteoblastic cells, was more affected than proliferation‐related parameters. The three PPIs showed similar qualitative and quantitative effects, but displayed some differences in the underlying intracellular signaling pathways. These results suggest that PPIs might have a direct deleterious effect on bone cells, with the possibility of decreased bone turnover.

1 January 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
BPBrígida Pinho
Brígida Pinho
SRSara D. Reis
Sara D. Reis
RHRichard C. Hartley
Richard C. Hartley
MMMichael P. Murphy
Michael P. Murphy
Jorge M. A. OliveiraJorge M. A. Oliveira
Jorge M. A. Oliveira
Superoxide generation by mitochondria respiratory complexes is a major source of reactive oxygen species (ROS) which are capable of initiating redox signaling and oxidative damage. Current understanding of the role of mitochondrial ROS in health and disease has been limited by the lack of experimental strategies to selectively induce mitochondrial superoxide production. The recently-developed mitochondria-targeted redox cycler MitoParaquat (MitoPQ) overcomes this limitation, and has proven effective in vitro and in Drosophila. Here we present an in vivo study of MitoPQ in the vertebrate zebrafish model in the context of Parkinson's disease (PD), and in a human cell model of Huntington's disease (HD). We show that MitoPQ is 100-fold more potent than non-targeted paraquat in both cells and in zebrafish in vivo. Treatment with MitoPQ induced a parkinsonian phenotype in zebrafish larvae, with decreased sensorimotor reflexes, spontaneous movement and brain tyrosine hydroxylase (TH) levels, without detectable effects on heart rate or atrioventricular coordination. Motor phenotypes and TH levels were partly rescued with antioxidant or monoaminergic potentiation strategies. In a HD cell model, MitoPQ promoted mutant huntingtin aggregation without increasing cell death, contrasting with the complex I inhibitor rotenone that increased death in cells expressing either wild-type or mutant huntingtin. These results show that MitoPQ is a valuable tool for cellular and in vivo studies of the role of mitochondrial superoxide generation in redox biology, and as a trigger or co-stressor to model metabolic and neurodegenerative disease phenotypes.

22 September 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SRSara D. Reis
Sara D. Reis
BPBrígida Pinho
Brígida Pinho
Jorge M. A. OliveiraJorge M. A. Oliveira
Jorge M. A. Oliveira

20 December 2015 in Stem Cells International
Verified
Journal Article
Open access
PDF file
JCJoão Costa-Rodrigues
João Costa-Rodrigues
SRS Reis
S Reis
ACA Castro
A Castro
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Silicon (Si) is indispensable for many cellular processes including bone tissue metabolism. In this work, the effects of Si on human osteogenesis and osteoclastogenesis were characterized. Human mesenchymal stem cells (hMSC) and CD14+ stem cells, as osteoblast and osteoclast precursors, were treated with a wide range of Si concentrations, covering the physiological plasma levels. Si promoted a dose‐dependent increase in hMSC proliferation, differentiation, and function, at levels similar to the normal basal plasma levels. Additionally, a decrease in the expression of the osteoclastogenic activators M‐CSF and RANKL was observed. Also, Si elicited a decrease in osteoclastogenesis, which became significant at higher concentrations, as those observed after meals. Among the intracellular mechanisms studied, an upregulation of MEK and PKC signalling pathways was observed in both cell types. In conclusion, Si appears to have a direct positive effect on human osteogenesis, at basal plasma levels. On the other hand, it also seemed to be an inhibitor of osteoclastogenesis, but at higher concentrations, though yet in the physiological range. Further, an indirect effect of Si on osteoclastogenesis may also occur, through a downregulation of M‐CSF and RANKL expression by osteoblasts. Thus, Si may be an important player in bone anabolic regenerative approaches.